Compounds for the treatment of inflammatory diseases

US8173699B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Ralf Anderskewitz · Laupheim, DE
• Horst Dollinger · Schemmerhofen, DE
• Rolf Goeggel · Ulm, DE
• Birgit Jung · Laupheim, DE
• Joerg Kley · Mittelbiberach, DE
• Jurgen Mack · Biberach an der Riß, DE
• Peter Nickolaus · Warthausen, DE
• Rainer Walter · Biberach, DE

Key dates

• Filing date: Apr 2, 2010
• Grant date: May 8, 2012
• Expiry date: Apr 2, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of formula 1 and hetero derivatives thereofand the pharmacologically acceptable salts, enantiomers, racemates, hydrates, or solvates thereof, which are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin, or eyes, diseases of the peripheral or central nervous system or cancers, as well as pharmaceutical compositions which contain these compounds.